COVID-19 Vaccination Information
An Update Regarding NHCA COVID-19 Vaccine Supply -
This Update Is Current As Of February 25th, 2022:
At this time, Naval Health Clinic Annapolis (NHCA) is receiving COVID-19 vaccine for beneficiaries 5 years and above.
We are currently appointing ALL beneficiaries daily by appointment only.
Please click here to schedule your COVID-19 vaccination.
If you receive the vaccine at an alternate location, that is not a military treatment facility, please send us a copy of your COVID-19 vaccination card via secure messaging or fax it to us at 410.293.1163.
COVID-19 Vaccine Form
After you have been appointed for the COVID-19 vaccine, please review the Emergency Use Authorization and complete the DHA207 COVID-19 Immunization form.
About The COVID-19 Vaccine
Vaccines fight disease by producing an immune response within the body. Sometimes that means flu-like symptoms, such as aches, headache and fever. This is normal and a sign that your body is creating antibodies to protect you from COVID-19. DoD prioritization will be derived from the data-driven, national prioritization to help ensure fair and equitable access to everyone, especially groups that are disproportionally affected by the pandemic.
Going to Alternative Locations for COVID-19 Vaccinations
COVID-19 VACCINATION FAQ
What COVID-19 vaccine is offered at Naval Health Clinic Annapolis and Branch Clinics?
We currently provide the MODERNA (18 and older), Pfizer (12 and older), and Pfizer (5-11 years).
I heard that any Sailor who wants an immunization can come to NHCA and get one right now?
NHCA is currently scheduling all active duty and eligible beneficiaries. NHCA provides COVID-19 vaccinations by appointment only. You can schedule your appointment by clicking here.
When will everyone else, besides active duty, be able to get vaccinated at NHCA?
NHCA beneficiaries were notified through Secure Messaging of the availability for COVID-19 vaccinations on Thursdays and Fridays, by appointment only. Click here to schedule your appointment.
What is an Emergency Use Authorization?
Drugs and vaccines have to be approved by the Food and Drug Administration (FDA) to ensure that only safe and effective products are available to the American public. During public health emergencies, when there is good scientific reason to believe that a product is safe and is likely to treat or prevent disease, the FDA may authorize its use through an Emergency Use Authorization (EUA), even if definitive proof of the effectiveness of the drug or vaccine is not known. FDA pre-licensure approval is considered for treatment or prevention of diseases that are very serious..
What kind of information will be available to me before I receive the vaccine?
Each recipient of COVID-19 vaccine will receive a vaccine-specific Emergency Use Authorization (EUA) Fact Sheet for Recipients or Vaccine Information Sheet (VIS) from the FDA, which will provide the following information:
- Basic information on COVID-19, symptoms, and what to discuss with a health care provider before vaccination
- Who should and should not receive the vaccine
- That recipients have the choice to receive the vaccine
- Dosage and vaccine series information
- Risks and benefits of the vaccine
- An explanation of what an EUA is and why it is issued
- Any approved available alternatives for preventing COVID-19
- Additional resources
How many doses of vaccine will I need?
COVID-19 vaccines will be given in a two-dose series separated by 21 or 28 days, depending on the product. The first two doses should be of the same product. Boosters are recommended 5 months later for m-RNA vaccines. The booster dose is interchangeable.
How will I be able to keep track of what vaccine I got and when I need to get a second dose?
All vaccine recipients will be provided a copy of the CDC COVID-19 Vaccination Record Card after receipt of the vaccine. It is recommended that the second-dose appointment be made at the time of initial vaccinations, or instructions provided on procedures for second dose follow-up. If a vaccine recipient has a smartphone, it is recommended that they take a photo of the vaccination record card as a back-up copy and set a calendar reminder for receipt of the second dose.
If I’ve already recovered from COVID-19 infection, do I need to be vaccinated?
Because the duration of immunity from natural infection with COVID-19 is unknown, vaccine may have value in protecting people who have already had the disease. Early evidence suggests natural immunity from COVID-19 may not last very long, but more studies are needed to better understand this. Talk with your provider if you have been previously infected with COVID-19.
If I get vaccinated, do I still need to wear a mask and practice social distancing?
Masks and physical distancing will still be necessary until a large proportion of the population is vaccinated and the vaccine is proven to provide long-term protection. Global and national public health authorities are expected to continue to recommend wearing masks and practicing physical distancing, for everyone, until pandemic risk of COVID-19 is substantially reduced.
Are there certain people at increased risk for severe illness from COVID-19?
The risk for severe illness and death from COVID-19 increases with age, with the greatest risk among those aged 85 or older. Adults of any age with the following conditions are also at increased risk of severe illness: Cancer; chronic kidney disease, COPD; heart disease; weakened immune system; obesity; pregnancy; sickle cell disease; smoking; and type 2 diabetes mellitus. COVID-19 is a new disease. Currently there are limited data and information about the impact of many underlying medical conditions and whether they increase risk. Talk with your provider about your individual risk factors and appropriate precautions.
How do we know if the vaccine is safe? How will you monitor and track vaccine side effects?
DoD is confident in the stringent regulatory process and requirements of the FDA. Manufacturers are required to submit their raw data for the FDA to review. Safety, immune response, and efficacy data from the trial stages are submitted to the FDA before they are authorized for use and distribution. Per FDA requirements, DoD will be monitoring and tracking vaccine reports of vaccine side effects through various surveillance activities both internal and external to the DoD.
Will DoD provide vaccines for civilian employees and contractor staff working in military hospitals or clinics? How about working on installation or in depots and arsenals?
The DoD will offer vaccine to civilian and contractor staff.